Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...

Lollipops, lozenges and mouth sprays containing the addictive drug never should have been approved in the first place. | ...

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Public health officials and researchers say the drop may reflect multiple forces, including access to treatment and ...

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

Cayuga Health Systems is to separately receive $1.5 million in Tompkins Community Grant funding to support an intensive ...

On STAT's Readout LOUD podcast, Jonathan Wosen talks about Genentech shutting down its cancer immunology team, and the ...

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Decreased regulations for the substance use disorder medication stand to provide patients with easier access to treatment ...

The FDA says it received three reports of dogs becoming ill after eating the product. The company disputes this.

On September 17, the Health Resources and Services Administration (HRSA), which administers the prescription drug discount ...

Dr. Stephen Loyd, who has been treating patients with substance use disorder since he got sober two decades ago, says ...